Equities

OrthoPediatrics Corp

OrthoPediatrics Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)29.21
  • Today's Change-0.85 / -2.83%
  • Shares traded3.00
  • 1 Year change-14.54%
  • Beta1.1831
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 53 surgical and specialized bracing systems.

  • Revenue in USD (TTM)175.07m
  • Net income in USD-25.12m
  • Incorporated2007
  • Employees247.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
KIDS:NMQ since
announced
Transaction
value
Boston Orthotics & ProstheticsDeal completed08 Jan 202408 Jan 2024Deal completed-3.63%22.00m
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pacific Biosciences of California Inc188.87m-400.38m555.96m796.00--1.13--2.94-1.50-1.500.70991.810.11252.056.69237,275.10-23.85-16.19-26.63-17.8126.0137.35-211.99-136.217.14-22.460.6444--56.2920.592.39--36.68--
Surmodics Inc120.82m-1.40m557.71m376.00--4.7676.264.62-0.0955-0.09558.558.280.65972.095.64321,332.40-0.7638-1.85-0.8909-2.1874.0282.93-1.16-2.983.22-4.460.1999--32.6510.2794.37---27.02--
Paragon 28 Inc235.44m-59.07m574.51m430.00--3.91--2.44-0.7132-0.71322.841.760.77030.60496.63547,539.60-19.33---23.48--76.67---25.09--1.70-5.300.4295--19.30--28.94------
Quanterix Corp129.33m-39.71m594.49m441.00--1.77--4.60-1.04-1.043.408.770.30782.374.60293,265.30-9.45-15.96-10.30-17.6657.4252.79-30.71-53.798.99--0.00--15.9626.6066.56--20.07--
Orthofix Medical Inc771.65m-120.49m611.73m1.63k--1.14--0.7928-3.21-3.2120.5514.350.86541.176.49472,245.40-13.51-8.88-16.22-10.9667.1872.37-15.62-9.281.13-4.940.2005--62.0610.51-666.60--30.01--
Iradimed Corp69.48m18.64m623.73m148.0033.657.8332.048.981.461.465.456.290.81091.556.03469,485.3021.7613.1623.8514.5877.2176.5526.8321.468.25144.050.0068.1323.0016.5934.0222.2297.77--
AxoGen Inc173.48m-16.54m642.98m426.00--6.72--3.71-0.3829-0.38294.012.180.91171.627.43407,237.10-8.69-13.92-9.93-15.8476.9879.74-9.53-20.282.32-2.940.3297--14.7413.6324.98--17.70--
Simulations Plus Inc66.98m9.65m645.45m192.0068.053.5745.649.640.4740.4743.299.040.3603--5.57348,843.805.197.205.497.6172.5377.6114.4021.29----0.0045.7010.5214.96-20.206.0212.910.8548
SI-Bone Inc150.71m-40.85m660.02m344.00--3.99--4.38-1.00-1.003.703.970.65861.546.67438,107.60-17.85-27.88-19.57-30.9477.6985.03-27.10-51.098.12--0.18--30.5220.1929.25--52.62--
Mesa Laboratories Inc223.71m-250.31m694.70m736.00--4.61--3.11-46.43-46.4341.4327.870.41312.516.29303,956.50-46.23-9.20-50.62-9.8862.2760.60-111.89-28.331.371.330.5848---1.3215.95-27,438.28--15.260.00
Cytek Biosciences Inc197.71m-17.56m695.66m645.00--1.79--3.52-0.1327-0.13271.492.960.3921.544.19292,470.40-3.48---3.89--54.97---8.88--6.38--0.0083--17.67---571.58------
Orthopediatrics Corp175.07m-25.12m707.30m247.00--1.91--4.04-1.10-1.107.6515.330.40450.42864.61708,793.50-5.80-5.40-6.43-5.9374.6275.09-14.35-15.921.96-44.230.0261--21.6220.91-1,767.25--28.29--
Standard Biotools Inc136.30m-164.66m783.14m534.00--1.53--5.75-0.9018-0.90180.66061.370.25612.255.73255,243.50-22.29-28.17-26.55-33.6046.6751.58-87.05-74.853.53--0.0974--8.57-1.2060.73--50.06--
Castle Biosciences Inc287.59m-3.10m846.80m610.00--2.0084.792.94-0.1346-0.134610.4515.300.63027.387.44471,457.40-0.6791-9.43-0.7383-10.1781.8680.58-1.08-28.467.92--0.0238--60.3857.3514.41--117.94--
Alphatec Holdings Inc540.28m-180.91m872.26m839.00--51.90--1.61-1.34-1.344.000.28470.77361.137.30643,959.50-25.90-30.97-33.24-39.4769.4466.02-33.48-46.221.21-4.590.9273--37.4539.38-23.36--67.92--
Embecta Corp1.12bn69.70m906.50m2.20k13.02--8.370.81021.211.2119.36-13.240.88822.1111.60508,590.905.53--7.91--66.42--6.23--1.612.061.88---0.7703---68.52------
Data as of Sep 19 2024. Currency figures normalised to OrthoPediatrics Corp's reporting currency: US Dollar USD

Institutional shareholders

43.59%Per cent of shares held by top holders
HolderShares% Held
Brown Capital Management LLCas of 30 Jun 20242.59m10.71%
Brown Advisory LLCas of 30 Jun 20241.62m6.68%
Braidwell LPas of 30 Jun 20241.11m4.58%
BlackRock Fund Advisorsas of 30 Jun 20241.11m4.57%
Granahan Investment Management, LLCas of 30 Jun 2024998.67k4.12%
The Vanguard Group, Inc.as of 30 Jun 2024885.10k3.66%
Wellington Management Co. LLPas of 30 Jun 2024746.38k3.08%
Wasatch Advisors LPas of 30 Jun 2024535.30k2.21%
New York State Common Retirement Fundas of 30 Jun 2024508.92k2.10%
Riverbridge Partners LLCas of 30 Jun 2024458.10k1.89%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.